Serratus Anterior Plane Block in Patients Undergoing Mastectomy
Summary
This is a randomized, interventional prospective study. Patients (n=66) undergoing mastectomies with or without tissue expander will be randomized to receive a supra-serratus or sub-serratus regional plane block prior to surgery. The main effect to be measured is total opioid consumption 24 hours after the operation. Secondary endpoints include measuring a change between pre-and post-operative pain scores, patient satisfaction of pain control during first 24 hours after the operation, presence of postoperative nausea and vomiting, duration of sleep on first postoperative night, and block performance time and length of stay, between the two treatment arms.
Timeline
- Start
- 2017-04-01
- Primary completion
- 2020-03-01
- Completion
- 2020-03-01
Outcome
Met primary endpoint
paper Subjects who received a deep SAPB required 30% less oral morphine equivalents (OME) (113.5 mg vs. 147 mg, p = 0.009) PMID 34364099 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ropivacaine | Other / unclassified | 0.35 % | Other |
| Subject | Ropivacaine | Other / unclassified | 20 ml | Other |
| Subject | Ropivacaine | Other / unclassified | 30 ml | Other |